Key takeaways
- Retatrutide (GLP-III / Triple G) is a synthetic triple-agonist reference peptide.
- It is studied in vitro at three receptor targets: GLP-1, GIP and glucagon.
- CAS 2381089-83-2 · MW 4731.3 g/mol · verified per batch by HPLC and LC-MS.
- Supplied strictly as a reference material for in-vitro laboratory research.
What retatrutide is
Retatrutide — also written GLP-III or "Triple G" — is a synthetic peptide that has become one of the most-searched compounds in metabolic research. It is supplied as a lyophilized reference standard for in-vitro laboratory study only; Peptide Cyprus makes no human-use or efficacy claims.
Why "triple" agonist
In published in-vitro research, retatrutide is described as a single molecule that engages three receptor targets — GLP-1, GIP and glucagon. This triple-agonism is precisely what makes it a subject of metabolic-signalling and energy-balance research models.
Molecular data
Retatrutide carries CAS 2381089-83-2, a molecular weight of 4731.3 g/mol and formula C221H342N46O68. As a reference material it is characterised by this data and verified per batch by HPLC and LC-MS.
Handling in the lab
Store lyophilized at −20 °C, protected from light. Reconstitute with bacteriostatic water for laboratory measurement, then keep refrigerated at 2–8 °C. The reconstitution calculator gives concentration and draw volumes.
Frequently asked
Research use only. This reference material is for in-vitro laboratory research. Not for human or animal consumption.
